Study of Epcoritamab as a Consolidation Therapy in CLL/SLL

Clinical trial NCT07108998 · RECRUITING

Trial details

NCT number: NCT07108998
Sponsor: Zulfa Omer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

CLL/SLL CLL SLL Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Small Lymphocytic Lymphoma Variant Chronic Lymphocytic Leukemia Variants

Start date: 2025-08-22
Primary completion: 2027-07-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.